Skip to main content
SpringerLink
Log in

Attention Deficit Hyperactivity Disorder and Its Treatment in Geriatrics

  • ADHD (G Kulkarni, Section Editor)
  • Published:
Current Developmental Disorders Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The main purpose of this review is to understand how attention deficit hyperactivity disorder (ADHD) affects geriatrics (elderly population).

Recent Findings

ADHD is a common neuropsychiatric condition, which is not well studied in geriatrics. Current literature does not have too much information on effects of ADHD in geriatrics. ADHD in elderly population is accompanied by various comorbidities such as anxiety and depression.

Summary

This review will provide an overview of existing literature on prevalence of ADHD in elderly population along with the comorbidities and available treatment options for the same.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Kuntsi J, Wood AC, Rijsdijk F, Johnson KA, Andreou P, Albrecht B, et al. Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors. Arch Gen Psychiatry [Internet]. 2010 Nov [cited 2019 Aug 23];67(11):1159–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21041617.

  2. Liddle EB, Hollis C, Batty MJ, Groom MJ, Totman JJ, Liotti M, et al. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J Child Psychol Psychiatry Allied Discip. 2011;52(7):761–71.

    Article  Google Scholar 

  3. Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev [Internet]. 2000 Jan [cited 2019 Aug 23];24(1):7–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10654654.

  4. Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–8.

    Article  Google Scholar 

  5. •• Tice P, Hunter D, Bose J, Hedden S, Ringeisen H, Casanueva C, et al. DSM-5 changes: implications for child serious emotional disturbance. 2016;(June):73. This study reports the details of DSM-5 changes.

  6. •• Kooij JJS, Michielsen M, Kruithof H, Bijlenga D. ADHD in old age: a review of the literature and proposal for assessment and treatment. Vol. 16, expert review of Neurotherapeutics. Taylor and Francis ltd; 2016. p. 1371–81. This study provides a review on ADHD in old age.

  7. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol. 1995;23(6):729–49.

    Article  CAS  Google Scholar 

  8. •• Willoughby MT. Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations. J Child Psychol Psychiatry [Internet]. 2003 Jan [cited 2020 Jan 9];44(1):88–106. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12553414This study reports how ADHD symptoms develop from childhood to adolescence.

  9. Faraone SV, Biederman J, Keenan K, Tsuang MT. Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients. Psychol Med. 1991;21(1):109–21.

    Article  CAS  Google Scholar 

  10. •• Torgersen T, Gjervan B, Lensing MB, Rasmussen K. Optimal management of ADHD in older adults. Vol. 12, neuropsychiatric disease and treatment. Dove medical press ltd.; 2016. p. 79–87. This study provides details on how ADHD should be managed in elderly population.

  11. Kooij JJS, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CAT, Hodiamont PPG. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817–27.

    Article  Google Scholar 

  12. • Michielsen M, Semeijn E, Comijs HC, Van De Ven P, Beekman ATF, Deeg DJH, et al. Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. Br J Psychiatry. 2012;201(4):298–305 This study provides details on prevalance of ADHD in elderly patients.

    Article  Google Scholar 

  13. •• Das D, Cherbuin N, Easteal S, Anstey KJ. Attention deficit/hyperactivity disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study. PLoS one [Internet]. 2014 [cited 2020 Jan 9];9(1):e86552. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24489743. This study provides details on how symptoms of ADHD appear in elderly patients.

  14. • Guldberg-Kjär T, Johansson B. Old people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65-80. Nord J psychiatry [Internet]. 2009 [cited 2020 Jan 9];63(5):375–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19308795. This study reports how elderly patients had self-reported childhood ADHD.

  15. •• Michielsen M, Comijs HC, Semeijn EJ, Beekman ATF, Deeg DJH, Sandra Kooij JJ. The comorbidity of anxiety and depressive symptoms in older adults with attention-deficit/hyperactivity disorder: a longitudinal study. J Affect Disord. 2013;148(2–3):220–7 This study documents the comorbdities related to ADHD in elderly patients.

    Article  Google Scholar 

  16. Semeijn EJ, Comijs HC, Kooij JJS, Michielsen M, Beekman ATF, Deeg DJH. The role of adverse life events on depression in older adults with ADHD. J Affect Disord [Internet]. 2015 Mar 15 [cited 2020 Jan 9];174:574–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25562670.

  17. Semeijn EJ, Korten NCM, Comijs HC, Michielsen M, Deeg DJH, Beekman ATF, et al. No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder. Int Psychogeriatr. 2015;27(9):1467–76.

    Article  CAS  Google Scholar 

  18. •• Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Psychopharmacological treatment of ADHD in adults aged 50+: an empirical study. J Atten Disord [Internet]. 2015 May [cited 2020 Jan 9];19(5):380–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24681898. This study provides details on prevalance of ADHD in elderly patients.

  19. Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G. ADHD burden of illness in older adults: a life course perspective. Qual Life Res [Internet]. 2012 Jun [cited 2020 Jan 9];21(5):795–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21805205 .

  20. Cortese S, Moreira-Maia CR, St Fleur D, Morcillo-Peñalver C, Rohde LA, Faraone S V. Association between ADHD and obesity: a systematic review and meta-analysis. Vol. 173, American Journal of Psychiatry. American Psychiatric Association; 2016. p. 34–43.

  21. Catal F, Topal E, Soylu N, Ozel Ozcan O, Celiksoy MH, Babayiğit A, et al. Psychiatric disorders and symptoms severity in preschool children with atopic eczema. Allergol Immunopathol (Madr). 2016;44(2):120–4.

    Article  CAS  Google Scholar 

  22. Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Pract [Internet]. 2015 Jan [cited 2020 Jan 9];15(1):4–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24134430.

  23. •• Manor I, Rozen S, Zemishlani Z, Weizman A, Zalsman G. When does it end? attention-deficit/hyperactivity disorder in the middle aged and older populations. Vol. 34, clinical neuropharmacology. 2011. p. 148–54. This study summarizes how ADHD affects eldelry population.

  24. Chen Q, Hartman CA, Haavik J, Harro J, Klungsøyr K, Hegvik TA, et al. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: a population-based cross-sectional study. PLoS One. 2018;13(9).

  25. • Henry E, Jones SH. Experiences of older adult women diagnosed with attention deficit hyperactivity disorder. J Women Aging. 2011;23(3):246–62 This study summarizes how ADHD affects eldelry women.

    Article  Google Scholar 

  26. Michielsen M, Comijs HC, Aartsen MJ, Semeijn EJ, Beekman ATF, Deeg DJH, et al. The relationships between ADHD and social functioning and participation in older adults in a population-based study. J Atten Disord [Internet]. 2015 May [cited 2020 Jan 9];19(5):368–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24378286 .

  27. •• Michielsen M, Comijs HC, Semeijn EJ, Beekman ATF, Deeg DJH, Kooij JJS. Attention deficit hyperactivity disorder and personality characteristics in older adults in the general Dutch population. Am J Geriatr psychiatry [Internet]. 2014 Dec [cited 2020 Jan 9];22(12):1623–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24656507. This study explains how ADHD may affects eldelry Dutch population.

  28. Kendall T, Taylor E, Perez A, Taylor C. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. Bmj. 2008;337(7672):751–3.

    Google Scholar 

  29. Seixas M, Weiss M, Müller U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol. 2012;26:753–65.

  30. Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol [Internet]. 2014 Mar [cited 2020 Jan 9];28(3):179–203. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24526134.

  31. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–35.

    Article  CAS  Google Scholar 

  32. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004;7:77–97.

  33. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry [Internet]. 2005 Mar 1 [cited 2019 Aug 28];57(5):456–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15737659 .

  34. Rösler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):120–9.

    Article  Google Scholar 

  35. Chang F, O’Hare AM, Miao Y, Steinman MA. Use of renally inappropriate medications in older veterans: a national study. In: Journal of the American Geriatrics Society. Blackwell Publishing Inc.; 2015. p. 2290–7.

  36. •• da Silva MA, Louza M. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate. J Atten Disord [Internet]. 2008 may [cited 2020 Jan 9];11(6):623. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18417727. This is case-study of an elderly woman with ADHD who received treatment with methylphenidate and recovered.

  37. Lavretsky H, Reinlieb M, Cyr NS, Siddarth P, Ercoli LM, Senturk D. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2015;172(6):561–9.

    Article  Google Scholar 

  38. Dolder CR, Davis LN, McKinsey J. Use of psychostimulants in patients with dementia. Ann Pharmacother. 2010;44:1624–32.

  39. Adler LA. Adult ADHD. Psychiatr Ann. 2018;48(7):316.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Balanced Wellbeing LLC, 10840 N US Highway 301, Oxford, FL, 34484, USA

    Parikshit Deshmukh & Dhara Patel

Authors
  1. Parikshit Deshmukh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dhara Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parikshit Deshmukh.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on ADHD

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deshmukh, P., Patel, D. Attention Deficit Hyperactivity Disorder and Its Treatment in Geriatrics. Curr Dev Disord Rep 7, 79–84 (2020). https://doi.org/10.1007/s40474-020-00194-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40474-020-00194-x

Keywords

Search

Navigation